Antiretroviral therapy coverage in Jordan
Jordan: Antiretroviral therapy coverage was 64.0% in 2024. ▲ Rising
Antiretroviral therapy coverage in Jordan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
In 2024, antiretroviral therapy coverage in Jordan stood at 64.0%. That is the highest value across all 25 years on record.
The figure is up 14.3% on the previous year and up 73.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Jordan peaked at 64.0% in 2024 and was at its lowest, 11.0%, in 2000.
Jordan ranks 97th of 143 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage in Jordan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 11.0% | — |
| 2001 | 12.0% | +9.1% |
| 2002 | 13.0% | +8.3% |
| 2003 | 13.0% | +0.0% |
| 2004 | 14.0% | +7.7% |
| 2005 | 19.0% | +35.7% |
| 2006 | 21.0% | +10.5% |
| 2007 | 24.0% | +14.3% |
| 2008 | 26.0% | +8.3% |
| 2009 | 30.0% | +15.4% |
| 2010 | 33.0% | +10.0% |
| 2011 | 35.0% | +6.1% |
| 2012 | 39.0% | +11.4% |
| 2013 | 38.0% | -2.6% |
| 2014 | 37.0% | -2.6% |
| 2015 | 38.0% | +2.7% |
| 2016 | 44.0% | +15.8% |
| 2017 | 47.0% | +6.8% |
| 2018 | 52.0% | +10.6% |
| 2019 | 56.0% | +7.7% |
| 2020 | 57.0% | +1.8% |
| 2021 | 44.0% | -22.8% |
| 2022 | 49.0% | +11.4% |
| 2023 | 56.0% | +14.3% |
| 2024 | 64.0% | +14.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.3% | 11.0% | 30.0% | 10 |
| 2010s | 41.9% | 33.0% | 56.0% | 10 |
| 2020s | 54.0% | 44.0% | 64.0% | 5 |
Countries ranked near Jordan
- 97 Gabon 64.0% compare
- 97 Lao People's Democratic Republic 64.0% compare
- 100 Bulgaria 62.0% compare
- 100 Costa Rica 62.0% compare
- 100 Somalia 62.0% compare
More health data for Jordan
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9463 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 842.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 470 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.048 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.13 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Jordan?
- Antiretroviral therapy coverage in Jordan was 64.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Jordan?
- The highest recorded value was 64.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Jordan?
- The lowest recorded value was 11.0% in 2000.
- How does Jordan rank for antiretroviral therapy coverage?
- Jordan ranks 97th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Jordan?
- Over the last ten years it is up 73.0%. The long-run trend across the full record is rising.
- Where does this Jordan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.